Riskpilot← Back to searchSign inGet full accessIntervacc AB
ABActiveOrg 5562381748Västertorpsvägen 135Veterinary activities · NACE 7500Est. 198310-19 employees
Revenue 2024
SEK 2,8M
-48% vs 2023
EBITDA margin
-1951.0%
+9% vs 2023
Equity ratio
89.8%
Financial strength
Net profit 2024
SEK -75,9M
+23% vs 2023
| Revenue | SEK 2,8M | -48% |
| EBITDA | SEK -54,6M | +9% |
| Net profit | SEK -75,9M | +23% |
| Total assets | SEK 220,3M | -25% |
| Equity | SEK 197,8M | -28% |
| Employees | — | — |
Legal name
Intervacc AB
Org number
5562381748
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
22 december 1983
Share capital
SEK 15 147 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning och utveckling samt affärsverksamhet inom vaccinområdet och därmed förenlig verksamhet.
Address
Västertorpsvägen 135
Phone
+4684494650
Email
amanda.beijar@nordvacc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 259 | 6 951 | 5 422 | 2 800 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −1 906 | −1 058 | −6 476 | −8 671 | −14 105 | −15 004 | −19 276 | −39 146 | −60 124 | −54 629 |
| Depreciation & amort. | −101 | −72 | −140 | −8 460 | −86 | −71 | −104 | −14 874 | −18 634 | −18 508 |
| EBIT | −2 007 | −1 130 | −6 616 | −17 131 | −14 191 | −15 075 | −19 380 | −54 020 | −78 758 | −73 137 |
| Net financials | 12 480 | −10 045 | −237 | −40 050 | −6 | 73 | 53 | 270 | 2 122 | 1 761 |
| Profit before tax | 13 173 | −8 075 | −6 852 | −57 156 | −15 260 | −19 108 | −23 111 | −55 116 | −89 172 | −75 948 |
| Tax | 5 | −313 | 1 513 | 2 540 | −0 | −0 | −0 | −0 | −9 677 | −0 |
| Net profit | 13 178 | −8 388 | −5 339 | −54 616 | −15 260 | −19 108 | −23 111 | −55 116 | −98 849 | −75 948 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 167 579 | 166 900 | 199 422 | 194 772 | 243 515 | 368 360 | 348 641 | 295 216 | 293 581 | 220 282 |
| Equity | 146 330 | 147 593 | 189 086 | 186 619 | 229 721 | 354 032 | 330 921 | 281 825 | 273 700 | 197 752 |
| Long-term debt | 12 552 | 6 997 | 417 | 145 | 0 | 0 | 222 | 183 | 142 | 106 |
| Short-term debt | 8 572 | 12 171 | 9 777 | 7 963 | 13 794 | 14 328 | 17 498 | 13 208 | 19 739 | 22 424 |
| Total debt | 21 124 | 19 168 | 10 194 | 8 108 | 13 794 | 14 328 | 17 720 | 13 391 | 19 881 | 22 530 |
EBITDA margin
-1951.0%
This company
15.8%
Market median
-12448% vs market
20152024
Equity ratio
89.8%
This company
38.2%
Market median
+135% vs market
20152024
Return on equity
-38.4%
This company
18.4%
Market median
-309% vs market
20152024
Net profit margin
-2712.4%
This company
8.1%
Market median
-33586% vs market
20152024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
KJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KL Chief Auditor | Chief Auditor | 2020 | — | — |
JE Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Intervacc AB 
Nord Vacc Läkemedel AktiebolagBoard members of Intervacc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Andreas Andersson | Chief Executive Officer | 0 companies |
| Carl Johan Dalsgaard | Chief Executive Officer | 0 companies |
| Kjell Jonas Sohlman | Chief Executive Officer | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Newton Aguiar | Board of Directors | 0 companies |
| Edwin Thomas William Torr | Board of Directors | 0 companies |
| Björn Magnus Sjöstrand | Chairman | 0 companies |
| Niels Erik Feveile Holck | Board of Directors | 0 companies |
| Camilla Eva M Ramfelt Mc Carthy | Board of Directors | 0 companies |
| Erling Lennart Johansson | Board of Directors | 0 companies |
| Björn Ingemar Odlander | Board of Directors | 0 companies |
| Emil Anders Billbäck | Board of Directors | 0 companies |
| Bengt Mikael Guss | Board of Directors | 0 companies |
| Lisen Nina Magdalena Fredricson | Board of Directors | 0 companies |
| Carl Erik Mathias Uhlén | Board of Directors | 0 companies |
| Ingrid Boel Elisabeth Sundvall | Board of Directors | 0 companies |
| Michela de Carli | Board of Directors | 0 companies |
| Bengt Stefan Ståhl | Board of Directors | 0 companies |
| Bert Urlings | Board of Directors | 0 companies |
| Jan-Ingmar Flock | Board of Directors | 0 companies |
| Torben Vedel Stahl Jørgensen | Board of Directors | 0 companies |
| Sven Håkan Björklund | Chairman | 0 companies |